Procter & Gamble Health Limited (BOM:500126)
India · Delayed Price · Currency is INR 5,334.05
+173.15 (3.36%)
At close: May 6, 2026
Procter & Gamble Health Market Cap
Procter & Gamble Health has a market cap or net worth of 88.54 billion as of May 6, 2026. Its market cap has increased by 3.23% in one year.
Market Cap
88.54B
Enterprise Value
85.74B
Revenue
13.49B
Ranking
n/a
PE Ratio
30.21
Stock Price
5,334.05
Market Cap Chart
Since June 14, 1999, Procter & Gamble Health's market cap has increased from 9.75B to 88.54B, an increase of 808.51%. That is a compound annual growth rate of 8.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 85.67B | -9.48% |
| Dec 31, 2025 | 94.63B | 8.85% |
| Dec 31, 2024 | 86.94B | 5.90% |
| Dec 29, 2023 | 82.10B | 23.12% |
| Dec 30, 2022 | 66.69B | -24.14% |
| Dec 31, 2021 | 87.91B | -22.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca Pharma India | 205.43B |
| Granules India | 173.27B |
| Rubicon Research | 159.80B |
| Jubilant Pharmova | 147.37B |
| Caplin Point Laboratories | 130.03B |
| CORONA Remedies | 105.60B |
| Viyash Scientific | 89.10B |
| Sanofi India | 78.49B |